IDH3A and central nervous system cancer: Recent studies have shown that 2-hydroxyglutarate (2-HG), which is a product of isocitrate dehydrogenase (IDH)-mutant glioma, plays a key role in cancer metabolism reprogramming [6], with particular attention to metabolic alterations in the tumor microenvironment of glioma.